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Abstract 52	
Sungri/96 vaccine strain is considered the most potent vaccine providing long-term 53	
immunity against peste des petits ruminants (PPR) in India. Previous studies in our laboratory 54	
highlighted induction of robust antiviral response in an interferon independent manner at 48 55	
h and 120 h post infection (p.i.). However, immune response at the earliest time point 6 h p.i. 56	
(time taken to complete one PPRV life cycle), in PBMCs infected with Sungri/96 vaccine virus 57	
has not been investigated. This study was taken up to understand the global gene expression 58	
profiling of goat PBMCs after Sungri/96 PPRV vaccine strain infection at 6 h post infection 59	
(p.i.). A total of 1926 differentially expressed genes (DEGs) were identified with 616 - 60	
upregulated and 1310 - downregulated. TLR7/TLR3, IRF7/IRF1, ISG20, IFIT1/IFIT2, IFITM3, 61	
IL27 and TREX1 were identified as key immune sensors and antiviral candidate genes. 62	
Interestingly, type I interferons (IFNα/β) were not differentially expressed at this time point as 63	
well. TREX1, an exonuclease which inhibits type I interferons at the early stage of virus 64	
infection was found to be highly upregulated. IL27, an important antiviral host immune factor 65	
was significantly upregulated. ISG20, an antiviral interferon induced gene with exonuclease 66	
activity specific to ssRNA viruses was highly expressed. Functional profiling of DEGs showed 67	
significant enrichment of immune system processes with 233 genes indicating initiation of 68	
immune defense response in host cells. Protein interaction network showed important innate 69	
immune molecules in the immune network with high connectivity. The study highlights 70	
important immune and antiviral genes at the earliest time point. 71	
Keywords: Microarray, PPRV, PBMCs, STRING protein-protein interactions, Ingenuity 72	
pathway analysis. 73	
Introduction 74	
 Peste-des-petits ruminant’s virus (PPRV), is an important viral pathogen of sheep and 75	
goats that causes devastating disease Peste-des-petits ruminants (PPR), which is spreading 76	
5	
extensively over the last two decades causing significant economic loses in developing 77	
countries (Albina et al., 2013; Banyard et al., 2010). PPRV is a single stranded (ss) RNA virus 78	
that belongs to the genus Morbillivirus and Family Paramyxoviridae. The PPRV genome 79	
encodes six structural proteins nucleoprotein (N), a viral RNA-dependent polymerase (L), an 80	
RNA-polymerase phosphoprotein co-factor (P), a matrix protein (M), a fusion protein (F) and 81	
a hemagglutinin protein (H) and two non-structural proteins C and V proteins. The C protein 82	
of morbilliviruses mediates efficient viral replication in peripheral blood cells in host by 83	
blocking the induction of type I interferons (Escoffier et al., 1999; Boxer et al., 2009). These 84	
non-structural proteins (C and V) in morbilliviruses and the paramyxoviruses, play an efficient 85	
role in virus replication, its virulence and help the virus in evading the host immune defense 86	
mechanisms by blocking type I IFN signaling pathway. Studies by many researchers have 87	
shown that the non-structural proteins of the paramyxoviruses inhibit the type I interferon 88	
(IFNα/β) response (Garcin et al., 1999, Shaffer et al., 2003 and Ramachandran et al., 2008). 89	
Recently, PPRV V protein was found to bind MDA-5 and its overexpression was shown to 90	
block IFN-β pathways (Bernardo et al., 2017). Previous transcriptome studies in our 91	
laboratory highlighted induction of robust antiviral response in an interferon independent 92	
manner at 48 h and 120 h post infection (p.i.) (Manjunath et al., 2017). However, immune 93	
response at the earliest time point 6 h p.i. (time taken to complete one PPRV life cycle), in 94	
PBMCs infected with Sungri/96 vaccine virus has not been investigated. 95	
       Interferons (IFNs) are the family of the cytokines, which inhibit viral growth inducing an 96	
antiviral state in host cells at the early stage of infection and play a critical role in modulating 97	
adaptive immune responses. Type I IFNs (IFN-α and IFN-β) commonly referred as “viral IFNs” 98	
are directly induced when the viral conserved molecular patterns called pathogen associated 99	
molecular patterns (PAMPs) are recognized by the pattern recognition receptors (PRRs) of 100	
the host cells. Type I interferon (IFN) gene induction in host cells against viral infections is a 101	
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consequence of activation of virus responsive elements, controlled by key regulators called 102	
interferon regulatory factors (IRFs mainly IRF-3 and 7). The induction of type I IFNs as 103	
secreted factors bind to the cell surface transmembrane receptors called interferon alpha 104	
receptor (IFNAR) on cells adjacent to infected cells and activates downstream JAK-STAT 105	
pathway. The activated STAT proteins translocates into the nucleus and binds to interferon 106	
stimulated responsive elements (ISREs) present at the upstream of the interferon stimulated 107	
genes (ISGs) activating many ISGs, which ultimately exerts the antiviral effect synergistically 108	
with other cytokines and chemokines (Pitha-Rowe and Pitha., 2007). Thus, interferon 109	
stimulated genes (ISGs) along with other cytokines and chemokines help in establishing an 110	
antiviral state in infected host cells. Interestingly, few RNA viruses including PPRV, have 111	
developed unique mechanisms to counterattack the host interferon (IFN) responses by 112	
subverting the host interferon signaling and thus, establish infection evading host innate and 113	
adaptive immune defenses (Bernardo et al., 2017; Nanda and Baron., 2006; Pauli et al., 2008; 114	
Nan et al., 2014). 115	
       Therefore, in the present study, the transcriptomic signatures in PPRV infected PBMCs 116	
at 6 h post infection (p.i) was analyzed to identify important innate immune / antiviral genes 117	
induced, and candidate genes driving interferon (IFN) evasion at early stages of PPRV 118	
infection. The results in the present study along with our previous observations (Manjunath et 119	
al., 2017; Manjunath et al., 2015) will add important protective innate immune signatures 120	
stimulated by Sungri/96 PPRV vaccine virus from early time point to the later stages of PPRV 121	
infection in an interferon independent manner. 122	
2. Materials and Methods123	
2.1. Animals, blood collection and screening animals for PPRV antibodies: All 124	
experimental procedures in the present study were approved by Institute Animal Ethics 125	
Committee (I.A.E.C No.F.1.53/2012-13-J.D.). Blood was collected from goat kids (5 months 126	
7	
old, n=5) screened negative for PPRV antibodies using competitive ELISA (c-ELISA) (Singh 127	
et al., 2004) kit and serum neutralization test (SNT) (Dhinakar Raj et al., 2000). Blood 128	
collected from animals negative for PPRV antibodies with percentage inhibition (PI) values 129	
less than 40 was used for isolating Peripheral blood mononuclear cells (PBMCs) and further 130	
studies. 131	
2.2. Isolation of PBMCs and PPRV Infection Confirmation Peripheral blood mononuclear 132	
cells (PBMCs) from PPRV negative goats were isolated from fresh, heparinized venous blood 133	
by density gradient centrifugation on Histopaque-2000 and was washed thrice with sterile 134	
phosphate buffered saline (PBS), the cells were finally resuspended in RPMI-1640 135	
supplemented with 10% fetal bovine serum and antibiotics (100 IU/ml penicillin, 100 μg/ml 136	
streptomycin). Viability of the cells was assessed using trypan blue exclusion test and the 137	
cells were found to be more than 95% viable. PBMCs were seeded at a density 1 X 106 viable 138	
cells/ml in two 6 well plates, one serving as control and the other plate was used for virus 139	
infection. Goat PBMCs isolated were infected with purified (Ultracentrifuged) Sungri/96 PPRV 140	
vaccine virus at 1.0 MOI (multiplicity of infection) and incubated at 370C in 5% CO2 incubator 141	
for 1 h of virus adsorption. After 1 h of adsorption, the virus inoculum was removed, 142	
centrifuged to collect the lymphocytes as they are in suspension, washed with fresh RPMI 143	
medium and added back to the wells. Fresh RPMI medium was added to wells and incubated 144	
upto 6 h post infection (p.i). The control (mock-infected) PBMCs on the other hand just 145	
received RPMI medium. Finally, the infected cells along with the control (mock-infected) 146	
PBMCs in duplicates were harvested at 6 h post-infection (p.i) and were processed for RNA 147	
isolation. Cells from three wells were combined per replicate sample. This time point was 148	
chosen to give enough time for the establishment of infection and for the completion of one 149	
viral life cycle (for PPRV 6-8 h). Experiments were performed in duplicates using RNA 150	
samples from two independently infected cell cultures for analysis. PPRV infection in PBMCs 151	
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was confirmed with N gene PCR and qRT-PCR. RNA isolated from control and the infected 152	
PBMCs was reverse transcribed to cDNA and N gene was amplified and quantified as 153	
previously (Manjunath et al., 2015). 154	
2.3. RNA preparation for microarray analysis: Total RNA was isolated from the PPRV 155	
infected and control PBMCs using Trizol reagent (Invitrogen). The quality and the integrity of 156	
the RNA samples isolated were determined using the Agilent RNA 6000 Nano Kit on the 157	
Agilent 2100 Bioanalyzer (Agilent Technologies) and the RNA was quantified on ND-1000 158	
Spectrophotometer. Labeling of the complementary RNA (cRNA) samples was performed as 159	
detailed in the agilent one-colour microarray based gene expression analysis protocol. Briefly, 160	
200ng of total RNA was used for amplification and labeling step using Agilent Quick Amp 161	
Labelling kit (Agilent Technologies) in presence of Cy3-CTP. Amplified cRNA samples were 162	
purified and the dye incorporation rates were measured before hybridization with ND-1000 163	
Spectrophotometer. 164	
2.4. Microarrays and Hybridization: The labeled samples were hybridized according to the 165	
one-color microarray based gene expression analysis (part number G4140-90040). In brief, 166	
1.65 μg of Cy3-labelled fragmented cRNA was hybridized overnight (at 650 C for 16 h) to 4 x 167	
44K Agilent Bos taurus microarrays. Since Capra hircus genome was not completely 168	
annotated, Bos taurus microarrays were used based on the fact that the average identity 169	
across exon sequences between Bos taurus and Capra hircus was 93.77% (Fontanesi et al., 170	
2010). After overnight hybridization, the arrays were washed with Triton X-102 added gene 171	
expression hybridization buffer I for 1 min at room temperature followed by wash with pre-172	
warmed gene expression hybridization buffer II for 1 min at 370 C. The hybridized microarrays 173	
were scanned using standard protocols and fluorescence signals were detected using 174	
Agilent’s Microarray scanner system (G2505C Scanner, Agilent Technologies, USA). Agilent 175	
9	
feature extraction software (FES) was used to process the scanned raw microarray image 176	
files to text files for the data analysis. 177	
2.5. Microarray data analysis and Identification of differentially expressed genes 178	
(DEGs): The sample files generated from microarray experiment were processed with agilent 179	
feature extraction software and then subjected to bioinformatics analysis using GeneSpring 180	
GX10 software (Agilent Technologies). The RMA algorithm conducts background correction, 181	
followed by quantile normalization and probe summarization. Overview of the experiment and 182	
the microarray analysis followed in the present study is highlighted in Figure 1. Differentially 183	
expressed genes (DEGs) statistically significant based on fold change ≥ 3 and P-value < 0.05 184	
were identified. A total of 1926 DEGs were identified of which 616 were upregulated and 1310 185	
genes were downregulated. 186	
2.6. Gene Ontology (GO) and Pathway analysis: The GO category based on biological 187	
process was retrieved for all the 1926 differentially expressed genes and also separately for 188	
all upregulated (616) and the downregulated genes (1310) using g:profiler (Reimand et al., 189	
2011). Further, analysis of enrichment of differentially expressed genes to canonical 190	
pathways was done using Cytoscape plugin ClueGO (Shannon et al., 2003), the enriched 191	
pathways were based on KEGG and REACTOME databases. 192	
2.7. Ingenuity Pathway analysis (IPA): The total differentially expressed genes were 193	
subjected to IPA analysis tool (IPA; QIAGEN, Redwood, CA). Also, the upregulated and the 194	
downregulated genes in isolation were analyzed by IPA. IPA analysis can be used to identify 195	
top significant canonical pathways (ranked by the z-score) and enriched networks in given 196	
set of input query genes. This tool in addition to identifying significant pathways can also 197	
predict downstream effects on the biological process, and activation/inhibition of the 198	
transcription factors from gene expression data set (Kramer et al., 2014). The differentially 199	
expressed genes (DEGs) identified from the microarray analysis were uploaded into IPA with 200	
	 10	
gene identifiers (ID) and corresponding fold changes. The same was followed separately for 201	
upregulated and the downregulated genes in the DEGs. Here, two parameters were used to 202	
calculate the significance between the genes from the input set and the canonical pathway: 203	
(1) Ratio which refers to number of genes in list to the total number of genes in the canonical 204	
pathway (2) P-value calculated by the Fisher’s exact test, determining the probability that 205	
there is an association between the input genes and the canonical pathway. Top 5 significant 206	
canonical pathways for the total DEGs and for upregulated and downregulated genes in 207	
isolation were identified and, the ratio and P-value were recorded.  208	
2.8. STRING analysis of protein-protein interactions (PPI) of DEGs:  The protein-protein 209	
interactions among upregulated and the downregulated genes (with fold change ≥ 5) in the 210	
study were predicted using STRING database (http://string-db.org/), which has known and 211	
predicted protein interactions. The STRING represents the functional association, and the 212	
basic interaction unit here gives the specific and productive relationship between the two 213	
proteins (Szklarczyk et al., 2015). The STRING new version 10.0 used to detect protein-214	
protein interactions (PPI) in this study covers more than 2031 organisms and for our study 215	
we used Bos taurus as closely related species to Capra hircus. The PPI analysis was carried 216	
out separately for upregulated and the downregulated genes. PPI for the upregulated genes 217	
consisted of 192 nodes and 171 edges. PPI analysis for the downregulated genes consisted 218	
of 392 nodes and 347 edges. Here, nodes represent the proteins and the edges represent 219	
the protein-protein associations. Nodes which were not connected were removed from the 220	
study. 221	
2.9. Validation of the microarray data with qRT-PCR: To confirm the results of our 222	
microarray analysis, among the identified differentially expressed genes (DEGs) some of the 223	
candidate DEGs of interest (Table 1) were validated using qRT-PCR. GAPDH, which is the 224	
most stable housekeeping genes for PPRV infected PBMCs observed previously (Manjunath 225	
11	
et al., 2015) was used as an endogenous control for the experiment. Total RNA was isolated 226	
from control and the infected PBMCs at 6 h p.i using the TRIzol reagent (Invitrogen, USA) 227	
according to the manufacturer’s instructions. The RNA quality was checked and quantified 228	
using nanodrop spectrophotometer (Thermo Scientific, USA). 100 ng of RNA was used to 229	
synthesize cDNA using Revert Aid First Strand cDNA synthesis kit. qRT-PCR was performed 230	
in Applied Biosystems 7500 fast machine using 2X SYBR green. A melt curve analysis was 231	
performed to know the specificity of the qPCR. For the test and endogenous control genes 232	
the percentage efficiency ranged between 90% and 100%. All the samples were assayed in 233	
triplicates. The relative expression of each sample was calculated using the 2−ΔΔCT method 234	
with uninfected control group as calibrator (Livak and Schmittgen, 2001). Student’s t-test was 235	
done in JMP9 (SAS Institute Inc, Cary, USA) and differences between groups were 236	
considered significant at P ≤ 0.05. 237	
3. Results238	
3.1. Infection confirmation and quantification of PPRV Infected cells: PPRV infection in 239	
PBMCs was confirmed by amplifying ‘N’ gene from the infected PBMCs at 6 h post infection 240	
(p.i.). The control cells were negative for N gene (Figure 2A). qRT-PCR quantified N gene 241	
expression at 6 h p.i, further confirmed PPRV infection in PBMCs (Figure 2B). 242	
3.2. Effects of early PPRV infection and Overview of differentially expressed genes 243	
(DEGS) at 6 h p.i 244	
 In response to PPRV infection at 6 h p.i, a total of 1926 genes were found to be differentially 245	
expressed in infected PBMCs based on fold change of (Fc) >±3 and P <0.05 (see 246	
Supplementary Table 1). Among these 1926 significant differentially expressed genes, 616 247	
and 1310 genes were found to be significantly upregulated and downregulated respectively 248	
at 6 h p.i. List of top 20 upregulated and downregulated genes are given in (Table 2) with their 249	
corresponding fold changes. Among the upregulated genes, SERTAD1 was found to be the 250	
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highly upregulated gene (Fold change 53.3). TREX1, the cytosolic exonuclease that plays a 251	
role in inhibiting induction of type I interferons was also highly upregulated (fold change 41.9). 252	
Many interferon related genes were found to be upregulated in our study namely, interferon 253	
induced protein with tetricopeptides (IFITs) viz. IFIT1 (fold change 17.3), IFIT2 (fold change 254	
3.4) and IFIT3 (8.5). Also, IFITM3 - Interferon inducible transmembrane proteins, an important 255	
antiviral immune factor against many pathogenic viruses was found to be upregulated (fold 256	
change 16.7). ISG20 (Interferon stimulated gene 20) which inhibits replication of many viruses 257	
was found to be highly upregulated (fold change 23.7) in PBMCs infected with PPRV at 6 h 258	
p.i. Among the interferon regulatory factors (IRFs), IRF1 (fold change 5.5) and IRF7 (fold259	
change 5.8) was found to be induced. IL-27, an antiviral cytokine was significantly upregulated 260	
after PPRV infection (fold change 19.3). The innate immune signaling cascade of events 261	
leading to the activation of the downstream effectors i.e interferon stimulated genes (ISGs) is 262	
initiated when pattern recognition receptors (PRRs) like TLRs are engaged with viral nucleic 263	
acids. In our study, TLR3, TLR7 and TLR8 were found to be upregulated after PPRV infection 264	
in PBMCs. Among the downregulated genes, IFNAR1 was found to be downregulated with a 265	
fold change 3.08. Among the caspases, caspase 8 (fold change 3.72) and caspase 4 (fold 266	
change 3.4) were significantly upregulated. 267	
3.3. Gene Annotation of Differentially expressed genes and their pathway analysis 268	
Significantly enriched biological processes among all the differentially expressed genes (i.e 269	
1926 DEGs), and among the upregulated and the downregulated genes in isolation were 270	
retrieved using g:profiler. Specific biology can be understood by analyzing the functional 271	
enrichment for upregulated and downregulated genes in isolation. Biological processes 272	
enriched among the 1926 DEGs are shown in Figure 3A, Supplementary table 2, Sheet1. The 273	
top significant biological process enriched among all the DEGs (1926) were immune system 274	
process (Genes: 233; P-value 2.89E-10), response to stress (Genes: 305; P-value 1.68E-05), 275	
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defense response (Genes: 135; P-value 2.24E-05), cell surface receptor signaling pathway 276	
(Genes: 226; P-value 2.49E-05), cytokine production (Genes: 74; P-value 0.000643). 277	
Biological process retrieved for 616 upregulated DEGs showed enrichment of immune system 278	
process, cytokine production, innate immune response and other immune defense processes 279	
(Figure 3B, Supplementary table 2 Sheet 2). Enriched biological processes of the 280	
downregulated genes showed enrichment of the normal cellular processes (Figure 3B, 281	
Supplementary table 2 Sheet 3). ClueGO analysis showed significant enrichment of antiviral 282	
mechanism by ISGs and interferon signaling among 1926 DEGs, and among the upregulated 283	
genes antiviral mechanism, interferon signaling, cytokine signaling, toll like receptor signaling 284	
pathway, etc., were found to be enriched (Figure 3C and 3D). Overall, the functional 285	
enrichment of DEGs at 6 h p.i. reflected that the infected PBMCs responded to the PPR virus 286	
infection by initiating the immune defense against the virus by alarming the immune sensors. 287	
3.4. Significant Pathway analysis of PPRV Infected PBMCs (6 h p.i.) 288	
 All the 1926 DEGs identified were uploaded to Ingenuity pathway analysis (IPA). The top 289	
canonical pathways enriched were Interferon (IFN) signaling (P=2.82E-08, ratio=0.417); role 290	
of BRAC1 in DNA damage response (P=1.65E-06, ratio=0.256); hepatic stellate cell 291	
activation (P=3.28E-06, ratio=0.182), role of JAK family kinases in IL-6 type cytokine signaling 292	
(P=9.37E-06, ratio=0.4) and glucocorticoid receptor signaling (P=2.36E-06, ratio= 0.15) 293	
(Figure 4A, Table 3). Further, the network analysis of these DEGs (1926) involved 25 294	
networks with top significant pathway being cell death and survival (score 40). This was 295	
followed by cellular assembly and organization, cellular function and maintenance with a 296	
score of 38. We then subjected upregulated (616) and downregulated DEGs (1310) to IPA. 297	
Statistically significant canonical pathways enriched in upregulated genes were interferon 298	
signaling (P=3.81E-12, ratio=0.361), T-helper cell differentiation (P=4.09E-08, ratio=0.183), 299	
communication between innate and adaptive immune cells (P=6.4E-07, ratio=0.146) (Figure 300	
14	
4B, Table 3). IFN-gamma and transcription factors (IRF7 and IRF1) were found to be the 301	
significant upstream regulators controlling significant number of upregulated genes. The 302	
important network associated with upregulated genes was antimicrobial response, 303	
inflammatory response and infectious diseases (score 27). IPA analysis of the downregulated 304	
genes did not show any relevant important canonical pathways related to the infection (Figure 305	
4C, Table 3). The network of the upregulated genes consisting of important innate immune 306	
molecules was generated from IPA and shown in figure 4D. 307	
3.5. Interaction Network Analysis (INA) of upregulated and downregulated genes 308	
Figure 5A and 5B shows predicted protein interaction networks of the upregulated and the 309	
downregulated genes encoding proteins. The network analysis of the upregulated genes 310	
showed average node degree 1.78 and clustering co-efficient to be 0.795. The network 311	
showed interaction between the early immune genes interferon regulatory factors - IRF1, 312	
IRF7; interferon stimulated gene - ISG20; and IFN-induced protein with tetricopeptide repeats 313	
- IFIT1, IFIT3 TLR7, IFNG and IL27 that play a vital role in early immune defense against the314	
invading virus in the host cell. There were other proteins, which were linked to this network of 315	
early innate immune proteins viz. DDX58 – an innate immune receptor that act as a cytosolic 316	
sensor for viral nucleic acids stimulating downstream immune signaling molecules for an 317	
effective antiviral response; and CXCL10, also known as IP10 (interferon inducible protein 318	
10) is involved in the regulation of lymphocyte recruitment in many viral infections and inhibits319	
viral replication. DDX58 and CXCL10 were found to be connected with IFNG, IRF1, IRF7, 320	
and ISG20 - immune network. The network analysis of downregulated genes showed average 321	
node degree 1.77 and the clustering co-efficient to be 0.764. 322	
3.6. Validation of microarray data by qRT-PCR 323	
 Microarray analysis of the viral infected cells in comparison to the control cells yielded large 324	
number of differentially expressed genes. It is important to identify candidate genes, which 325	
15	
play an important role in our experimental study and validate them by qRT-PCR. We validated 326	
nine candidate differentially expressed genes predicted to be antiviral and are important 327	
innate immune molecules against PPRV in PBMCs at the early stage of infection (6 h p.i). 328	
These DEGs expression in qRT-PCR was in concordance with microarray results except IFN-329	
ϒ (Figure 6). 330	
3.7. Immune signaling pathway of Sungri/96 vaccine virus updated 331	
The pathway predicted at 6 h post infection was also found to be IFN independent similar to 332	
our previously mentioned pathway (Manjunath et al., 2017). Based on the transcriptome 333	
analysis at 6 h p.i. and qRT-PCR validation of important candidate genes, we updated our 334	
previously mentioned pathway with unique innate immune molecules that were predicted at 335	
this earliest time point of infection (supplementary table 3). 336	
4. Discussion:337	
Global gene expression profiling helps to identify candidate genes involved in host-virus 338	
interactions and host immune defense molecules activated or inhibited under viral infection. 339	
In our previous study, we reported the transcriptional profile and immune response 340	
mechanism(s) at 120 h p.i, and 48 h vs 120h response in PBMCs infected with Sungri/96 341	
vaccine strain (Manjunath et al., 2015; Manjunath et al., 2017). The immune protection 342	
mechanisms induced by Sungri/96 vaccine virus at an earliest time point (6 h p.i.) vis -a vis 343	
the transcriptional signatures have not been explained. Therefore, in the present study the 344	
transcriptional response of goat PBMCs at 6 h p.i., which is the time required to complete one 345	
complete life cycle of PPRV (Naveen Kumar et al., 2013) has been explored. 346	
           At 6 h p.i., 1926 significant differentially expressed genes (FC > 3) that were mostly 347	
associated with the immune and defense responses were identified. Innate immunity acts as 348	
a first line of defense against invading pathogens and is activated when pathogen associated 349	
molecular patterns (PAMPs) are engaged to pattern recognition receptors (PRRs) like TLRs 350	
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(Thompson et al., 2011). Toll like receptors (TLRs) - TLR7, TLR3, TLR8 and TLR2 were 351	
significantly upregulated in this study. TLR 7 was the most highly upregulated PRR in our 352	
study along with TLR 8, both of which are involved in the recognition of single stranded (ss) 353	
RNA viruses (Jansen and Thomson, 2012; Lund et al., 2004). These upregulated TLRs -3,7 354	
and 8, were identified to further initiate downstream immune signaling cascades induced by 355	
Sungri/96 vaccine virus. Similarly, previous studies with Hepatitis C Virus (HCV – ssRNA 356	
virus) and other ssRNA viruses identified these TLRs (TLR7 and TLR8) in initiating the 357	
antiviral response (Zhang et al., 2016; Lund et al., 2004; Deibold et al., 2004). 358	
Although different TLRs are activated when engaged to different PAMPs, they cross 359	
path to transcriptionally activate downstream interferon regulatory factors (like IRF3, IRF7) 360	
and NFKB, which when phosphorylated translocate into the nucleus activating type I 361	
interferons. Interestingly, in our study type I interferons (IFN-α and IFN-β) were not 362	
differentially expressed, although, interferon induced genes were found to be induced. This 363	
supports the recent observation that the paramyxovirus (including PPRV) non-structural 364	
proteins (C and V proteins) play a role in inhibiting type I IFN production (Bernardo et al., 365	
2017; Andrejeva et al., 2004). In the present study, at 6 h p.i. we hypothesized that interferon 366	
induced genes must have been activated in an interferon (IFN) independent manner as 367	
observed at 48 and 120 h p.i. (Manjunath et al., 2017). TREX1, which was highly upregulated 368	
in the study is an exoribonuclease, besides being an exonuclease (Yuan et al., 2015). TREX1 369	
may act as negative regulator of induction of type I interferons in PPRV infected PBMCs. 370	
Similar effect of TREX1 was observed recently in HIV infection (Wheeler et al., 2016). TREX1 371	
could be one of the breaks, having inhibitory effect on type I IFN signaling pathway, allowing 372	
virus to replicate in the initial stages of the infection. Further, functional studies need to be 373	
done to study the effect of TREX1 on PPRV replication. IRFs and interferon induced genes 374	
that were upregulated in this study were IRF7, IRF1, IFIT2, IFIT1, IFIT3, IFITM3, OAS2 and 375	
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OAS1Z. ISG20, an interferon induced gene with exonuclease activity specific against ssRNA 376	
viruses (Espert et al., 2003) was found to be upregulated. ISG 20 was linked to other important 377	
innate immune genes in the interaction network asserting its crucial role in immune defense. 378	
Cells exhibiting increased expression of ISG20 are resistant to RNA virus infection and thus, 379	
play an important role in host antiviral innate immune defense (Espert et al., 2005 and Zhou 380	
et al., 2011). The increased expression of ISG20 highlights its specific activity against PPRV 381	
(ssRNA virus) at the early stages of the infection. Recently, it was shown ISG20 inhibits 382	
replication of influenza A virus by interacting with nucleoprotein (Qu et al., 2016) and inhibits 383	
Hepatitis B virus replication by binding directly to epsilon stem loop structure of viral RNA (Liu 384	
et al., 2017). IRF3 and IRF7 are the main regulators of immune responses to viruses (Lazear 385	
et al., 2013). Upregulation of IRF7 in our study indicated host cell responses to trigger 386	
downstream signaling cascades against the invading virus. IRF7 is known to induce the 387	
interferon stimulated genes (ISGs) by stimulating type I interferons (Pulit-Penaloza et al., 388	
2012). However, IRF7 upregulation, induction of interferon induced genes and inhibition of 389	
type I interferon response in PPRV infected PBMCs highlighted induction of ISGs in an IFN 390	
independent manner at the early time point of infection. This may be due to the high degree 391	
of homology between the ISRE and IRF binding element (IRF-E) consensus sequences, 392	
IRF7/IRF3 may bind directly to induce ISGs (Morin et al., 2002; Schmid et al., 2010; 393	
Manjunath et al., 2017). Thus, the data suggests activation of interferon induced genes in 394	
PPRV infected PBMCs in the absence of type I interferons induction. Similar IFR7 activation 395	
of interferon induced restriction factor BST2 was observed in absence of type 1 interferon 396	
signaling in Parainfluenza virus V5 protein infection (Bego et al., 2012). 397	
Viral infections in host cells induce pro-inflammatory cytokines and chemokines 398	
response (Mogensen and Paludan, 2001). Increased expression of interleukins viz. IL-27, IL-399	
19, IL-6, IL-10 and IL-21 and chemokines - CCL8, CCL3, CCL25 and CCL4 in response to 400	
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PPRV infection was observed in this study. IL-27, an IL-12 family of cytokines was found to 401	
be highly upregulated and may be a host immune factor produced in response to PPRV 402	
infection. Its role as host immune factor has also been identified in Influenza A virus infection 403	
(Liu et al., 2012). IL-27 has both pro and anti-inflammatory properties and is known to play 404	
an important role in bridging innate and adaptive immune response (Villarino et al., 2004). IL-405	
27 also synergizes with other interleukins viz. IL-12 to trigger IFN-γ production of naïve CD4+ 406	
T cells promoting Th1 differentiation (Hunter 2005; Yoshida and Miyazaki, 2008). IFN-γ was 407	
found to be significantly upregulated in the present study. Recently, Sungri/96 vaccine was 408	
shown to induce strong IFN-γ production and higher number of CD4+ T cells specifically 409	
responding to the virus (Hodgson et al., 2018). Thus, in the present study high expression of 410	
IL-27 represents its possible antiviral role in PPRV infection. In addition, STAT proteins viz. 411	
STAT1, STAT2 and STAT3 showed increased expression in this study. Therefore, the 412	
findings from the present and previous studies highlights mechanism of host immune 413	
response induced by Sungri/96 vaccine and emphasize the importance of stimulating type I 414	
interferon response lacking in present vaccine, which may otherwise provide longer duration 415	
of immune protection in hosts. 416	
4.1 Updated pathway after inclusion of early immune signaling molecules that were 417	
uniquely expressed at an early time point in Sungri/96 vaccine virus infected PBMCs 418	
Microarray analysis of PPRV infected PBMCs at 6 h p.i., followed by qRT-PCR validation of 419	
key candidate genes helped to include early immune signaling molecules that would aid in 420	
triggering robust antiviral response (Figure 7). This study also confirmed the inhibition of type 421	
I interferons at the earliest time point (6 h p.i.), which corroborated with our previous 422	
observations at 48 h and 120 h p.i. (Manjunath et al., 2017). Lymphotropic PPR virus enters 423	
the PBMCs via SLAM receptor (Adombi et al., 2011) or other alternate receptors expressed 424	
on the surface of PBMCs. PPR virus (negative sense ssRNA) after entering the host cell 425	
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uncoats releasing viral nucleic acid, which is transcribed in the cytoplasm to establish infection 426	
in host cells. The residual ssRNA genome not replicating in cytoplasm are strong inducers of 427	
type I interferon response at initial stages of the infection (Yan et al., 2010). TREX1, an 428	
exoribonuclease degrades ssRNA (Yuan et al., 2015), which could otherwise strongly trigger 429	
type I IFN response in host cells on being recognized by RIG1. TREX1 in our study was 430	
significantly upregulated (FC = 41.9) indicating its role in inhibiting type I IFN response in early 431	
PPRV infection by degrading ssRNA. This TREX1 was observed only at 6 h p.i. and was not 432	
found in our previous transcriptome studies at 48 h and 120 h p.i. (Manjunath et al., 2017). 433	
Alternatively, virus is endocytosed and the viral PAMPs gets engaged to PRRs i.e TLRs 434	
located on the endosomes. TLR7/8 on the endosomal surface recognize ssRNA to initiate 435	
downstream immune signaling cascade. These were upregulated in the present study. TLRs 436	
activates interferon regulatory factors called IRFs via adaptor TRIM21 which was also 437	
upregulated in the present study. Activated TLR7/8 induces the activation of IRF7 during virus 438	
infection. IRF7 normally expressed at low levels is upregulated in response to virus infection 439	
(Liang et al., 2007). IRF7 was significantly upregulated in our study. Activation of TLR7, IRF7 440	
and TRIM21 was also observed at later time points of infection in our previous study 441	
(Manjunath et al., 2017). IRF7 once activated translocates into the nucleus binding directly to 442	
the interferon stimulated responsive elements (ISREs) due to the homology between the two 443	
and thus, activates transcription of interferon induced genes (Ning et al., 2005; Schmid et al., 444	
2010). The interferon induced genes after transcription are translated in the cytoplasm, the 445	
translated interferon induced genes along with other antiviral proteins act synergistically to 446	
exert antiviral response. ISG20 and IFIT1 were the unique interferon induced genes 447	
significantly upregulated at 6 h p.i. along with IL-27, an important antiviral host immune factor. 448	
These molecules along with the innate immune molecules identified in our previous study 449	
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(Manjunath et al., 2017) help in triggering a robust antiviral response in an interferon 450	
independent manner in PBMCs infected with Sungri/96 vaccine virus. 451	
5. Conclusion452	
The study highlighted key early immune sensors and antiviral molecules like IL-27, IFIT1 and 453	
ISG20 at the earliest time point - 6 h p.i. (time taken to complete one PPRV life cycle), in 454	
PBMCs infected with Sungri/96 vaccine virus. The study also confirms the inhibition of type I 455	
interferon response at this time point supporting our observation at 48 h and 120 h p.i. TREX1 456	
is predicted to be the possible molecule responsible for type I interferon inhibition. 457	
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Figure legends: 603	
Figure 1: Overview of the experiment and microarray analysis:  Depicts the experimental 604	
method followed to generate microarray data and further analysis. Steps include identification 605	
of the differentially expressed genes (DEGs), functional enrichment of the DEGs, gene 606	
interaction network analysis, pathway analysis and validation of the candidate DEGs. 607	
Figure 2: PPRV infection confirmation: A. PPRV infection confirmation at 2h p.i. (Lane 2) 608	
and 6 h p.i. in PPRV infected PBMCs showing N gene amplicon of 351 bp (Lane 3) and the 609	
uninfected cells showed no N gene amplification (Lane 1). B. Fold changes for N gene 610	
expression quantified by qRT-PCR after normalization at 6 h p.i in comparison to 2h p.i.. 611	
Figure 3: Gene Ontology (GO) of differentially expressed genes (DEGs): A. GO category 612	
in terms of biological processes for all the DEGs (1926) was retrieved using g:profiler, 613	
significant biological processes (P < 0.05) are shown and the number represents the genes 614	
involved in the particular process. B. Significant biological processes retrieved separately for 615	
the upregulated and the downregulated genes are shown. C and D. Pathways enriched by 616	
clueGO analysis in total DEGs (1926) and the upregulated genes (616) respectively. The 617	
number on the graph represents the number of genes belonging to a particular term. 618	
Figure 4: Ingenuity pathway analysis (IPA): A, B and C. IPA analysis showing top five 619	
canonical pathways enriched in all DEGs (1926), upregulated genes (616) and 620	
downregulated genes (1310) respectively. D. Gene interaction network generated by IPA of 621	
upregulated transcripts at 6 h p.i. The interaction network showed the relationship between 622	
27	
important innate immune related genes. In the figure, the genes are displayed with various 623	
shapes, which actually represents the IPA defined functional class of gene product as 624	
indicated. The solid line indicates the direct interaction and the dotted line indicates the 625	
indirect interaction. 626	
Figure 5: STRING analysis of protein-protein Interaction networks: A and B. Protein-627	
protein interaction networks of upregulated and the downregulated genes respectively. The 628	
nodes represent the proteins and the edges represent the interactions between them. 629	
Figure 6: Validation of microarray results by qRT-PCR of selected genes: Nine candidate 630	
genes from the microarray analysis were validated with quantitative real time PCR (qRT-631	
PCR). Fold changes (2-ΔΔCt) for each gene is represented, calculated with control sample as 632	
the calibrator with standard error bar. Here levels not connected with same letter are 633	
significantly different. 634	
Figure 7: Updated immune signaling pathway in goat PBMCs infected with PPRV: PPR 635	
virus being lymphotropic infects PBMCs through SLAM/CD46 receptor. The virus enters the 636	
cells and gets uncoated, releasing viral nucleic acids in the cytoplasm, which then undergoes 637	
replication. Also, the virus enters into endosomes where the viral nucleic acids are released. 638	
PPRV ssRNA in the cytoplasm undergoes replication to establish infection in the cells, 639	
whereas the excess ssRNA not replicating are chewed by exoribonuclease TREX1, which 640	
could otherwise induce a strong type I IFN response in infected cells through RIG1. TREX1 641	
significantly upregulated in the present study may probably inhibit type I IFN response in 642	
PBMCs. The virus entering the endosomes releases the ssRNA, gets engaged to TLRs (TLR 643	
– 3, 7 & 8) and activates interferon regulatory factors (IRFs- 3,7 & 9) with the help of adaptor(s)644	
- TRIM14/21. Activated and phosphorylated IRFs translocate into the nucleus and bind to645	
interferon stimulated responsive elements (ISREs) activating interferon stimulated genes 646	
(ISGs). ISGs along with other immune molecule exert a strong antiviral response in PPRV 647	
28	
infected PBMCs. Upregulated and downregulated genes are indicated by up (↑) and down (↓) 648	
arrows respectively in the figure. The unique candidate genes expressed at early time point 649	
are coloured in blue. 650	
Legends to Supplementary Files: 651	
Supplementary file 1: List of differentially expressed genes and their fold change. This 652	
Supplementary file shows list of 1926 differentially expressed genes and their corresponding 653	
fold changes associated with them. 654	
Supplementary file 2:  GO in terms of biological process retrieved from g-profiler for 1926 655	
differentially expressed genes (Sheet 1), upregulated genes (Sheet 2) and downregulated 656	
genes separately (Sheet 3). This Supplementary file Sheet 1, Sheet 2 and Sheet 3 shows the 657	
significantly enriched processes among the biological processes in g-profiler for total 1926 658	
DEGs, upregulated genes and downregulated genes respectively. The genes involved in 659	
each process and their significant p-value has been indicated in this file. The minus log P 660	
values were used to construct the GO Fig.s. 661	
Supplementary file 3: List of 1926 differentially expressed genes identified in this study with 662	
their fold changes. The list also compares the log fold changes of 1926 DEGs presence in 663	
our pervious study i.e 48 h p.i. and 120 h p.i. The file shows the candidate genes identified in 664	
this study and validated, some of which are unique to early stages of PPRV infection. 665	
666	667	668	669	670	671	
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 672	
Table 1: Primers Sequences used for qRT-PCR 673	
 674	
675	676	677	
Genes Primer Sequence 
IFIT3 Forward: 		AAGGGTGGACACTGGTCAAG 
Reverse: 		AGGGCCAGGAGAACTTTGAT 
ISG20 Forward: TGCATGCACAGACATCCC 
Reverse: CTAACAGTCATCAGAGTGTAGCC 
IFN-ϒ Forward: CAGGAGCTACCGATTTCAGC 
Reverse: AGGCCCACCCTTAGCTACAT 
IFNα Forward: 	CAGCCTGGTCCTTACTCCTG 
Reverse: 	CTGCTCTGACAACCTCCCAG 
IFNβ Forward: 	GTGTCTCTCCACCACAGCTC 
Reverse: 	CGGAGGTAACCTGTTAGGCTC 
TREX1 Forward: GCATCTACTGGAACCAACCC 
Reverse: CAGGAAGGCCAGAAGGC 
IL-27 Forward: CTGCTTCCTCTCCCTGACAC 
Reverse: TTCCTCCTCATTCTCGTGCT 
TLR7 Forward: GCAGCCTGTTCTGGAAAATC 
Reverse: GAAGGGGCTTCTCAAGGAAT 
IRF7 Forward: 	GACACGCCCATCTTTGACTT 
Reverse: 	ACTGTCCAGGGAGGACACAC 
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  Table 2: List of top 20 upregulated and the downregulated genes in the present study with their 679	
corresponding fold change 680	
 681	
Top 20 Upregulated genes Fold Change Top 20 Downregulated genes Fold Change 
SERTAD1 53.4 EFHD1 -3937.9
TREX1 41.9 MTURN -1405.9
FN1 30.6 SYNE4 -180.6
TNFRSF11B 29.3 KCNK5 -72.9
TSGA10IP 26.4 TMEM39A -56.4
ISG20 23.8 VPS13A -15.6
TNFRSF11B 22.0 ITGAD -15.4
MAP1B 21.5 NUPR1L -13.8
LAG3 19.6 ITGAD -13.0
IL27 19.3 ABCA7 -12.9
IFNW1 18.3 PLD4 -12.0
EMC7 17.7 FAM92A1 -11.9
IFIT1 17.4 PON3 -11.8
IFITM3 16.7 CRABP2 -11.5
ERAP1 15.5 TGFBI -11.2
AKAP11 14.4 IFT122 -11.0
ACADM 14.2 KCNB2 -10.8
DDX58 14.2 RNF6 -10.8
FAM170B 14.1 ZNF280D -10.6682	683	684	685	
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  Table 3: Ingenuity Pathway Analysis (IPA) of 1926 DEGs, upregulated and downregulated genes with 687	
top significant canonical pathways and upstream regulators for each category  688	
 689	
IPA analysis of 1926 DEGs with the top canonical pathways and upstream regulators 
Top Cannonical Pathways P-value Ratio Upstream 
Regulators 
P-value
Intereferon (IFN) Signaling 2.82E-08 0.417 TGFB1 4.34E-26 
Role of BRCA1 in DNA damage 
response 
1.65E-06 0.256 TNF 3.70E-22 
Hepatic stellate cell activation 3.28E-06 0.182 B-Estradiol 8.35E-21 
Role JAK family kinases in IL6 
type cytokine signaling 
9.37E-06 0.4 LPS 4.29E-19 
Glucocorticoid receptor 
signaling 
2.36E-05 0.15 
IPA analysis of Upregulated DEGs with the top canonical pathways and upstream regulators 
Top Cannonical Pathways P-value Ratio Upstream 
Regulators 
P-value
Intereferon (IFN) Signaling 3.81E-12 0.361 IFNG 2.19E-35 
Th cell differentiation 4.09E-08 0.183 IFN-alpha 3.09E-33 
Type1 Diabetes Mellitus 
Signaling 
2.24E-07 0.136 IRF7 6.87E-30 
Communication between innate 
and adaptive immune cells 
6.40E-07 0.146 IRF1 9.16E-25 
Role of JAK1, JAK2 and TYK2 
in IFN signalling 
2.11E-06 0.292 
IPA analysis of Downregulated DEGs with the top canonical pathways and upstream regulators 
Top Cannonical Pathways P-value Ratio Upstream 
Regulators 
P-value
32	
Transcriptional regulatory 
network in embryonic stem cells 
1.07E-05 0.275 TGFB1 1.00E-10 
Role of BRCA1 in DNA damage 
response 
4.73E-04 0.167 B-Estradiol 1.07E-09 
Calcium signaling 1.41E-03 0.118 ESR2 1.26E-06 
cAMP mediated signaling 2.10E-03 0.109 TNF 1.77E-06 
UVC induced MAPK signaling 2.39E-03 0.19 690	691	692	
